Suomen Rokotepiste Oy

What Suomen Rokotepiste Oy does

Suomen Rokotepiste Oy is a Finnish private health-services company founded in early 2023 and headquartered in Helsinki. Operating under the brand "Rokotepiste" (Finnish for "vaccination point"), the company runs a nationwide pharmacy-based vaccination network, partnering with over 110 pharmacies across all major Finnish regions to deliver walk-in and pre-booked vaccinations. The core offering is a turnkey ("avaimet käteen") operating model that includes staff training and certification, responsible physician oversight, patient record integration with Kanta/Omakanta, nurse consulting, and a centralized appointment booking system provided by Ajas Oy. Following the May 2024 STM regulation that allowed pharmacists and practical nurses to administer vaccinations, Rokotepiste activated a pharmacist-led vaccination model and co-developed the national training curriculum with Farmasian Oppimiskeskus ry.

The company's product portfolio spans TBE (tick-borne encephalitis), influenza, COVID-19, pneumococcal, shingles (Shingrix), hepatitis A/B, HPV, RSV, MMR, chickenpox, tetanus/diphtheria, and a broad travel vaccine range, plus ancillary nurse services (ear irrigation, wound care, health checks). The company also participates in the FinDementia clinical research study with FVR and GSK, recruiting 35,000 elderly participants through partner pharmacies. Distribution is B2B2C: Rokotepiste sells turnkey service subscriptions to partner pharmacies, while consumers pay per-vaccination fees ranging from €49.90 (influenza) to €289.90 (RSV), with multi-dose package discounts.

Revenue is generated through three streams: per-vaccination fees from end consumers, training and certification services for pharmacists, and recurring subscription/turnkey service fees from partner pharmacies covering responsible physician services, nurse consulting, training, and administrative support. The company is privately held, founder-led (CEO Kalle Starck), with no external institutional funding disclosed, supported by a small core team of 8 employees augmented by partner-pharmacy staff and outsourced clinical personnel (e.g., staffing partner Apteam Oy).

Name

Suomen Rokotepiste Oy

Legal name

Suomen Rokotepiste Oy

Website

https://rokotepiste.fi

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Suomen Rokotepiste Oy operates a turnkey pharmacy-based vaccination service network across Finland, partnering with over 110 pharmacies to deliver walk-in and pre-booked vaccinations. The company trains pharmacy staff, provides responsible physician oversight, and integrates with Kanta patient records, charging per-vaccination and subscription fees.

Ownership category

akta.pro rank

Product category

Pharmacy-based Vaccination Services

NAICS

Offices of Other Health Practitioners (6213)

SIC

Services-Health Services (8000)

akta.pro primary industry

Immunization & Vaccine Clinics (HLAKAGAJ)

Keywords

• Pharmacy vaccination services
• Vaccination network
• Turnkey pharmacy services
• Vaccination training
• Travel vaccination services

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Vaccination service fees: Revenue is generated from per-vaccination fees charged to customers at partner pharmacies. Prices range from €49.90 for basic influenza vaccination to €289.90 for RSV vaccination. Multi-dose vaccine series are offered as discounted packages (e.g., TBE 3-dose package at €169.90 vs €62.90 per dose). Additional fees are charged for nurse consultation visits (€34–€50), injection administration (€32 per injection), and other health services such as ear irrigation (€49.90) and minor surgical procedures.
2. Training and certification services for pharmacies: The company provides vaccination training for pharmacists ('farmaseuttien rokotuskoulutus'), including theoretical and practical components. Training leads to a THL-approved certificate signed by the company's responsible physician. This supports the pharmacy network's ability to self-perform vaccinations.
3. Partnership/service fees from pharmacy network: Partner pharmacies pay for the complete operating model including responsible physician services, nurse consulting line, patient systems, training, and administrative support. This is structured as a franchise-like 'avaimet käteen' (turnkey) service agreement with each partner pharmacy.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Suomen Rokotepiste Oy is a Finnish healthcare startup that delivers a turnkey pharmacy-based vaccination service operating model. The company equips and certifies partner pharmacies to administer a broad range of vaccinations — including TBE, influenza, COVID-19, pneumococcal, shingles, hepatitis, HPV, RSV, MMR, chickenpox, tetanus/diphtheria, and travel vaccines — by providing responsible physician services, staff training, regulatory compliance (Soteri), Kanta/Omakanta patient record integration, and a centralized Ajas online booking system. Consumers access vaccinations either walk-in or by pre-booking at over 110 partner pharmacies across Finland.

Product overview

Suomen Rokotepiste Oy operates a nationwide pharmacy-based vaccination network under the Rokotepiste brand. The offering is a unified service model (not a software platform) consisting of core vaccination services delivered at partner pharmacies, supplemented by a pharmacist vaccination enablement module, a health point (Terveyspiste) setup service for pharmacies, a nurse reception services module, a vaccination reminder system, a FinDementia clinical research program, and pharmacist vaccination training. The core product is the network of vaccination services at partner pharmacies offering vaccines including TBE, influenza, coronavirus, pneumococcal, shingles, hepatitis, HPV, RSV, MMR, chickenpox, tetanus/diphtheria, and travel vaccines. The pharmacist vaccination model and training service (enabled by 2024 STM legislation) allow pharmacists to independently administer vaccinations. The Terveyspiste setup service supports pharmacies in establishing full health point operations with licensing, systems, and staff training. The company also participates in the FinDementia research study investigating shingles vaccine's effect on dementia prevention.

Differentiator

Problem solved

Functional benefit

Products and services

• TBE (tick-borne encephalitis) vaccination Tick-borne encephalitis vaccination offered at pharmacies across Finland, including a three-dose primary series and booster doses; offered with single-dose, two-dose package, and full three-dose package pricing (€62.90 single dose / €114.90 two-dose / €169.90 three-dose for adults).
• Influenza vaccination Annual standard influenza vaccination available at partner pharmacies (€49.90), with a high-antigen enhanced influenza vaccine offered for adults aged 60+ (€89.90). Available as bundles with pneumococcal or COVID-19 vaccines.
• COVID-19 (coronavirus) vaccination Coronavirus vaccination available at partner pharmacies from September 2024 for persons aged 12+ without a separate prescription; €149.90 single dose, with bundle pricing alongside influenza.
• Pneumococcal vaccination Pneumococcal vaccination offered in 20-valent (€135.00) and 21-valent (€168.90) formulations, available as a standalone vaccine or bundled with influenza vaccination at 11% off.
• Shingles (herpes zoster / Shingrix) vaccination Shingrix shingles vaccination for adults aged 50+ and immunocompromised adults aged 18+; two-dose series priced at €249.90 single dose or €479.00 two-dose package.
• Hepatitis A and B vaccinations Hepatitis A, B, and combined A+B vaccinations offered in adult and child formulations with single-dose, two-dose and three-dose series package pricing (e.g., combined HepA/B adult 3-dose package €309.90).
• Travel vaccinations Travel vaccines including yellow fever (€99), typhoid (€80.90), cholera (€134.90), rabies (€137.90), dengue (€169 / €315 two-dose), Japanese encephalitis (€199), meningococcal Menveo (€107.90), Trumenba B (€179.90), and polio (€74.90); available by appointment only at partner pharmacies.
• HPV vaccination Human papillomavirus vaccination protecting against HPV-caused cancers, priced at €249.90 and available by appointment only at partner pharmacies.
• RSV vaccination (Arexvy) Arexvy RSV vaccine for adults aged 60+ or immunocompromised adults, protecting against lower respiratory tract disease caused by RSV; priced at €289.90 per dose.
• MMR (measles, mumps, rubella) vaccination Measles, mumps, and rubella vaccination for children and adults, priced at €67.90 and available by appointment only at partner pharmacies.
• Chickenpox (varicella) vaccination Varicella vaccination preventing chickenpox and subsequent shingles risk, priced at €122.90 and available by appointment only at partner pharmacies.
• Tetanus and diphtheria vaccination Tetanus-diphtheria (€49.90) and tetanus-diphtheria-pertussis booster (€74.90) vaccinations administered on the standard 20-year booster schedule.
• Terveyspiste (Health point) setup service Turnkey health point ("Terveyspiste") establishment service for pharmacies, including company formation, Soteri licensing, responsible physician arrangement, nurse consulting line, staff training, insurance, and Kanta integration.
• Pharmacist vaccination training Vaccination training for pharmacists ("farmaseuttien rokotuskoulutus") including theoretical and practical injection training, with THL-approved certificate signed by the company's responsible physician. Developed in collaboration with Farmasian Oppimiskeskus ry.
• Nurse reception services (Hoitajan vastaanotto) Nurse consultation services at selected pharmacy health stations including ear irrigation (€49.90), ear examination (€13), wound care (€23), suture removal (€23), tick removal (€23), blood pressure measurement (€13), HbA1c test (€29), cholesterol test (€29), and health check packages.

Quantifiable outcome

• Vaccination services available at over 110 pharmacies across all of Finland
• +2 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature1 record

Partnerships

Nine partnerships are on record, tiered minor and core.

• Apteam OyminorOthers · 1 January 2024Apteam is a staffing company specializing in pharmaceutical personnel placement. Since 2024, Rokotepiste has worked with Apteam to provide vaccinating staff (pharmacists) to partner pharmacies through staff leasing arrangements.
• FVR – Suomen rokotetutkimus (Finnish Vaccination Research)coreStrategic or Co-development PartnerFVR is conducting the FinDementia study investigating whether GSK's Shingrix shingles vaccine reduces dementia incidence in adults aged 76+. Rokotepiste's partner pharmacies serve as study sites alongside FVR's own clinics. The study aims to recruit approximately 35,000 participants and follows them for a minimum of 3 years.
• GSK (GlaxoSmithKline)coreStrategic or Co-development PartnerGSK is the manufacturer of Shingrix (herpes zoster vaccine) used in the FinDementia study. The study is conducted by FVR in collaboration with GSK, selected wellbeing areas, and Rokotepiste's partner pharmacies.
• Suomen Partiolaiset ry (Scouts Finland)minorGTM or Marketing PartnerScouts Finland and Rokotepiste have a partnership providing discounted TBE vaccinations to registered scout members. Members receive TBE vaccination at a reduced price (€57.90 for under 18, €62.90 for adults with €5 discount). Rokotepiste also pays a commission per vaccination to support scout activities.
• Farmasian Oppimiskeskus ry (Pharmacy Learning Centre)coreStrategic or Co-development PartnerRokotepiste collaborated with Farmasian Oppimiskeskus ry in developing the content for the 'Farmasian ammattilainen rokottajana' (Pharmacy Professional as Vaccinator) course. The course provides theoretical and practical vaccination training for pharmacists.
• Ajas OycoreTechnology or IntegrationAjas Oy provides the net booking system (nettivaraus) used by Rokotepiste for online appointment booking across all partner pharmacies. Ajas also provides the patient information system for vaccination records.
• Kela (Social Insurance Institution of Finland)coreTechnology or IntegrationRokotepiste integrates with Kela's Omakanta system for patient record keeping. Vaccination records are registered in the national Kanta/Omakanta service, which is mandatory for all healthcare providers in Finland.
• Yliopiston Apteekki (University Pharmacy)coreChannel Partner/ Reseller/ DistributorYliopiston Apteekki operates pharmacy locations nationwide and is a key partner for Rokotepiste. Yliopiston Apteekki locations in Helsinki (Kesakulma, Malmi, Töölö, Viikki), Vantaa (Tammisto), Espoo (Iso Omena), Turku, Salo, Tampere, Oulu, Jyväskylä, Lahti, Joensuu, Lappeenranta, Savonlinna, Pori, and Kemi all offer Rokotepiste vaccination services.
• Over 100 independent partner pharmaciescoreChannel Partner/ Reseller/ DistributorThe company partners with over 100 independent pharmacies across Finland, ranging from small rural sub-pharmacies to larger urban pharmacies. These include pharmacies in Uusimaa, Pirkanmaa, Varsinais-Suomi, Satakunta, Kymenlaakso, Päijät-Häme, Kanta-Häme, Etelä-Pohjanmaa, Pohjanmaa, Pohjois-Pohjanmaa, Etelä-Karjala, Pohjois-Karjala, Etelä-Savo, Pohjois-Savo, Keski-Suomi, Kainuu, and Lappi regions.

Scale indicators6 records

Recent moves10 records

Expansion highlights10 records

Broad incumbents

• Walgreens Boots Alliance: US and European pharmacy operator with in-store Healthcare Clinics and pharmacy-led vaccination services. Provides a mature, at-scale example of pharmacy-enabled clinical service delivery relevant to Rokotepiste's model.
• CVS Health: US pharmacy and healthcare conglomerate that runs MinuteClinic retail clinics inside CVS pharmacies delivering vaccinations, testing, and nurse practitioner services. The scaled, established analogue of the pharmacy-based vaccination model Rokotepiste enables in Finland.
• Boots: UK high-street pharmacy chain offering travel vaccinations, flu jabs, and a range of in-store clinical services. Directly comparable in delivering pharmacist-administered vaccination services through a high-street retail footprint.

Direct peers

• DocMorris: Leading European online pharmacy and telehealth platform offering prescription fulfilment, consultations, and chronic care services across DACH and the Benelux. Comparable as a pharmacy-anchored, omnichannel health service business targeting self-pay customers.
• Terveystalo: Finland's largest private healthcare provider, operating clinics nationwide that deliver occupational health, vaccinations, and nurse-led services. Competes directly with Rokotepiste for Finnish self-pay and corporate vaccination customers through its own clinic footprint.
• Coronaria: Finnish private healthcare group operating clinics and occupational health services including vaccination programmes. Competes with Rokotepiste for Finnish employer and consumer vaccination demand through its own clinic network.
• Mehiläinen: Major Finnish private healthcare chain offering vaccinations, occupational health, and lab services across its own clinics. Targets the same consumer and employer customer base in Finland as Rokotepiste.
• Pihlajalinna: Finnish private healthcare and social services provider with clinics and occupational health operations. Competes with Rokotepiste for vaccination volumes, particularly in regional and corporate health segments.
• Passport Health: Largest North American network of dedicated travel and specialty vaccination clinics operating a turnkey clinic model. Closest international comparable in delivering standardised, multi-vaccine services through distributed locations under a shared brand.

Regional players

• Apotek Hjärtat: Sweden's largest pharmacy chain, owned by ICA Gruppen, offering in-store health services including vaccinations and health checks. Closest geographic peer demonstrating the Nordic pharmacy-based health service model that Rokotepiste operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/rokotepiste
• LinkedInlinkedin.com/company/suomen-rokotepiste-oy

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Suomen Rokotepiste Oy